Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
- PMID: 37655148
- PMCID: PMC10467587
- DOI: 10.21315/mjms2023.30.4.6
Characteristics of ABO Antibodies in Group O Malaysian Blood Donors
Abstract
Background: Haemolytic transfusion reactions (HTRs) due to anti-A and anti-B antibodies in Group O blood products are rare but potentially fatal. This study aimed to identify the prevalence of high ABO antibody titre and the immunoglobulin (Ig) classes (IgM only or with IgG) and the prevalence of haemolysin antibodies in Group O blood donors.
Methods: Plasma from Group O blood donors was tested by using antibody titration at room temperature. Titres ≥ 64 were considered high. The plasma was treated with 0.01 M dithiothreitol (DTT) to determine the presence of IgG antibodies and titre. IgG titres ≥ 64 were considered high. Tests for haemolysis were conducted by mixing the plasma with 3% fresh A1 and B cell suspensions and incubating at 37 °C. The haemolysis was observed macroscopically.
Results: Of 311 donors, 238 (76.5%) showed high anti-A and/or anti-B antibody titres. The highest antibody titre obtained was 256. Female and younger donors (< 40 years old) had higher anti-A and anti-B titres. The anti-B titre showed an association with gender (P < 0.001), and was high in female donors (77.8%). Males aged over 50 years old were found to have low mean titre antibodies. Most donors had both IgM and IgG ABO antibodies. The prevalence of haemolysins in our population was 3.5%.
Conclusion: Most of our O blood donors had a high ABO antibody titre but a low prevalence of haemolysins. Males aged over 50 years old are the best O donors for preventing HTRs, particularly when mismatch transfusion is required. We recommend a transfusion unit screen for ABO antibody titre in younger female donors (< 40 years old), to prevent the transfusion of high titre O blood products into non-O recipients.
Keywords: O group; anti-A; anti-B; antibody titres; haemolysin; haemolytic transfusion reaction.
© Penerbit Universiti Sains Malaysia, 2023.
Conflict of interest statement
Conflict of Interest None.
Similar articles
-
Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion.Transfus Med. 2020 Aug;30(4):317-323. doi: 10.1111/tme.12687. Epub 2020 Jun 2. Transfus Med. 2020. PMID: 32484285 Clinical Trial.
-
Haemolysin test for characterization of immune ABO antibodies.Indian J Med Res. 2003 Sep;118:125-8. Indian J Med Res. 2003. PMID: 14700345
-
Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation.Xenotransplantation. 2003 May;10(3):278-84. doi: 10.1034/j.1399-3089.2003.02060.x. Xenotransplantation. 2003. PMID: 12694548
-
Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review.Blood Rev. 2022 Nov;56:100989. doi: 10.1016/j.blre.2022.100989. Epub 2022 Jul 14. Blood Rev. 2022. PMID: 35871104
-
Anti-A and anti-B: what are they and where do they come from?Transfusion. 2015 Jul;55 Suppl 2:S74-9. doi: 10.1111/trf.13087. Transfusion. 2015. PMID: 26174901 Review.
References
LinkOut - more resources
Full Text Sources